These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17520443)

  • 61. Investigation of some materials as dry binders for direct compression in tablet manufacture. Part 7: Formulation and evaluation of ascorbic acid and phenobarbitone tablets.
    Asker AF; Saied KM; Abdel-Khalek MM
    Pharmazie; 1975 Jul; 30(7):466-70. PubMed ID: 1178765
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Fast relief from migraine attacks using fast-disintegrating sublingual zolmitriptan tablets.
    Mahmoud AA; Salah S
    Drug Dev Ind Pharm; 2012 Jun; 38(6):762-9. PubMed ID: 22023340
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The suitability of disintegrating force kinetics for studying the effect of manufacturing parameters on spironolactone tablet properties.
    Massimo G; Santi P; Colombo G; Nicoli S; Zani F; Colombo P; Bettini R
    AAPS PharmSciTech; 2003; 4(2):E17. PubMed ID: 12916899
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Design and evaluation of a new formulation of enalapril maleate tablet.
    Bibi R; Naqvi BS; Shoaib MH; Rahim N
    Pak J Pharm Sci; 2011 Apr; 24(2):211-5. PubMed ID: 21454172
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Taste masking of ondansetron hydrochloride by polymer carrier system and formulation of rapid-disintegrating tablets.
    Khan S; Kataria P; Nakhat P; Yeole P
    AAPS PharmSciTech; 2007 Jun; 8(2):Article 46. PubMed ID: 17622121
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Studies on cyclodextrin polymer. Part 1: The effect of CDP on indomethacin tablet formulation.
    Tarimci N; Celebi N
    Pharmazie; 1988 May; 43(5):323-5. PubMed ID: 3174808
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of variation in compaction force on properties of six direct compression tablet formulations.
    Khan KA; Rhodes CT
    J Pharm Sci; 1976 Dec; 65(12):1835-7. PubMed ID: 1032674
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Formulation and optimization of orally disintegrating tablets of sumatriptan succinate.
    Sheshala R; Khan N; Darwis Y
    Chem Pharm Bull (Tokyo); 2011; 59(8):920-8. PubMed ID: 21804234
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Preparation and evaluation of an orally fast disintegrating tablet formulation containing a hydrophobic drug.
    Comoglu T; Unal B
    Pharm Dev Technol; 2015 Jan; 20(1):60-4. PubMed ID: 24295202
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Formulation study for orally disintegrating tablet using partly pregelatinized starch binder.
    Mimura K; Kanada K; Uchida S; Yamada M; Namiki N
    Chem Pharm Bull (Tokyo); 2011; 59(8):959-64. PubMed ID: 21804239
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of friction between powder and tooling on the die-wall pressure evolution during tableting: Experimental and numerical results for flat and concave punches.
    Mazel V; Diarra H; Tchoreloff P
    Int J Pharm; 2019 Jan; 554():116-124. PubMed ID: 30395955
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Formulation development of stronger and quick disintegrating tablets: a crucial effect of chitin.
    Goel H; Kaur G; Tiwary AK; Rana V
    Yakugaku Zasshi; 2010 May; 130(5):729-35. PubMed ID: 20460872
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Influence of Prosolv and Prosolv:Mannitol 200 direct compression fillers on the physicomechanical properties of atorvastatin oral dispersible tablets.
    Gowda V; Pabari RM; Kelly JG; Ramtoola Z
    Pharm Dev Technol; 2015 Jun; 20(4):394-400. PubMed ID: 24397821
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Frosta: a new technology for making fast-melting tablets.
    Jeong SH; Fu Y; Park K
    Expert Opin Drug Deliv; 2005 Nov; 2(6):1107-16. PubMed ID: 16296813
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Formulation development of carvedilol compression coated tablet.
    Shah R; Patel S; Patel H; Pandey S; Shah S; Shah D
    Pharm Dev Technol; 2013; 18(4):906-15. PubMed ID: 21797662
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pharmacokinetic comparison of fast-disintegrating and conventional tablet formulations of risperidone in healthy volunteers.
    van Schaick EA; Lechat P; Remmerie BM; Ko G; Lasseter KC; Mannaert E
    Clin Ther; 2003 Jun; 25(6):1687-99. PubMed ID: 12860492
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Preparation and characterization of starch-metal silicate Co-precipitates--evaluation as tablet superdisintegrant.
    Singh I; Kaur B; Juneja P
    Polim Med; 2014; 44(3):157-66. PubMed ID: 25696940
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Epinephrine in Anaphylaxis: Preclinical Study of Pharmacokinetics after Sublingual Administration of Taste-Masked Tablets for Potential Pediatric Use.
    Rachid O; Rawas-Qalaji M; Simons KJ
    Pharmaceutics; 2018 Feb; 10(1):. PubMed ID: 29439456
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity.
    Bi Y; Sunada H; Yonezawa Y; Danjo K; Otsuka A; Iida K
    Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2121-7. PubMed ID: 8945778
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
    Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E
    AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.